Corcept Therapeutics
CORT
CORT
226 hedge funds and large institutions have $2.18B invested in Corcept Therapeutics in 2020 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 60 increasing their positions, 94 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more call options, than puts
Call options by funds: $23.9M | Put options by funds: $22.9M
5.33% less ownership
Funds ownership: 77.13% → 71.79% (-5.3%)
36% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 94
Holders
226
Holding in Top 10
7
Calls
$23.9M
Puts
$22.9M
Top Buyers
| 1 | +$14.8M | |
| 2 | +$12.3M | |
| 3 | +$10.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.92M |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
+$6.64M |
Top Sellers
| 1 | -$31M | |
| 2 | -$22.6M | |
| 3 | -$12.3M | |
| 4 |
Man Group
London,
United Kingdom
|
-$11.8M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$9.28M |